FEMSA Q4 Earnings Miss, Revenues Top Estimates on Segment Strength
FMX Q4 earnings miss estimates despite 34% y/y growth, as strong segment revenues and margin gains offset weakness in the Health segment and softer traffic.
Zacks·7d ago
More News
Hormel Foods Gears Up for Q1 Earnings: Key Insights for Investors
HRL's first-quarter results are likely to show modest sales growth, but elevated beef costs and turkey constraints may pressure earnings.
Zacks·9d ago
The J. M. Smucker Q3 Earnings on Deck: Is a Beat Likely for SJM?
SJM sees Q3 sales growth supported by Hostess and pricing actions, but rising green coffee costs and higher spending may have pressured quarterly earnings.
Zacks·10d ago
Beverage Stocks Earnings Roster Next Week: KDP, MNST, FMX, SAM
Beverage stocks enter fourth-quarter 2025 earnings under pressure from weak demand and costs, even as pricing, premiumization and health-focused launches offer support.
Zacks·13d ago
Monster Beverage Gears Up for Q4 Earnings: Here's What You Should Know
MNST eyes a strong Q4 as global energy drink demand, new flavors and pricing moves aim to boost growth and margins.
Zacks·14d ago
Boston Beer's Q4 Results: Is an Earnings Surprise in the Cards?
SAM's Q4 performance is likely to reflect seasonal weakness, softer volumes and hard seltzer declines as inventory cuts and macro headwinds squeeze margins.
Zacks·14d ago
FEMSA Q4 Earnings on The Horizon: Will It Surprise Investors?
FMX gears up for Q4 with revenues seen soaring 24.6% and EPS at $1.53, but margin pressures and cost headwinds may temper gains.
Zacks·15d ago
Keurig Dr Pepper Q4 Earnings Approaching: Will It Surprise Investors?
KDP eyes Q4 growth with revenues seen up 7.2% to $4.36B, but coffee weakness and inflation may test margins with Refreshment up 12.5% and EPS at 59 cents.
Zacks·15d ago
Diageo 1H26 Earnings Ready to Unfold: What Are the Chances of a Beat?
DEO gears up to report 1H26 results amid weakness in the United States and China, but strength in Europe, LAC and Africa could shape the earnings outcome.
Zacks·15d ago
Medifast's Q4 Earnings on Deck: What Could Shape MED's Results?
MED is likely to post a sharp Q4 revenue drop and a wider loss as active earning coaches decline and GLP-1 pressure weighs despite retention and pricing efforts.